Publish Time: 2026-11-12 Origin: Site
World Pneumonia Day
Managing pneumonia depends on timely insight into the inflammatory response, and on prompt clues to common respiratory pathogens. C-reactive protein (CRP), serum amyloid A (SAA), procalcitonin (PCT) and interleukin-6 (IL-6) are widely used laboratory indicators along this pathway. Antigen tests for influenza, respiratory syncytial virus (RSV), SARS-CoV-2, Mycoplasma pneumoniae and adenovirus help screen for pathogens that can cause or accompany lower respiratory infection.
Goldsite Diagnostics presents these offerings under “One-stop Inflammation/Pneumonia/CRP Solutions,” for clinics, pediatric departments, general practice, emergency rooms, central laboratories and STAT labs. Laboratory specific-protein systems and point-of-care platforms place the same indicators in different care settings, from outpatient assessment to inpatient monitoring, and from inflammation testing to pathogen screening.
CRP is produced by the liver. Blood levels rise when inflammation is present, so CRP can be used both to detect acute inflammation and to follow disease activity. In pneumonia and related lower respiratory infection, CRP is typically used in three situations:
| First assessment In clinics, general practice, pediatrics or the emergency room, CRP is used with symptoms and signs to gauge the current inflammatory response and support the next clinical step. | Admission baseline In hospital, a CRP result at admission provides a starting point for later comparison. | Treatment monitoring Repeat CRP during treatment shows whether inflammation is falling, and helps inform adjustments to care. |
Goldsite provides CRP on both laboratory and point-of-care platforms, including high-sensitivity and wide-range related assays, so departments can choose the format that fits their workflow.
SAA is also an acute-phase protein, and is often used alongside CRP in the assessment of infection and inflammation. In pneumonia-related care, SAA can support the initial inflammation assessment, and can be paired with CRP so that the inflammatory response is viewed through two markers.
Goldsite offers SAA on Aristo, GPP-100, Omlipo and FIA GO. Laboratories can also set a CRP+SAA inflammation combo and obtain both results in one request, which suits clinics, emergency rooms and laboratories that want a fuller inflammation profile.
PCT and IL-6 are used in infection-related monitoring. PCT is commonly used in hospital, emergency and critical-care settings to follow the infection burden and its change during treatment. IL-6 is a cytokine marker of the inflammatory response, and can be used in early inflammation and infection monitoring. FIA GO also offers a PCT/IL-6 combo, so both results can be reviewed at the same time point.
These assays fit departments that need serial observation, including the emergency room, intensive care, inpatient wards, and primary-care sites with point-of-care testing.
Pneumonia and related lower respiratory infections can be caused by a range of pathogens, including influenza virus, RSV, SARS-CoV-2, Mycoplasma pneumoniae and adenovirus. Antigen tests are used to screen for these pathogens quickly, giving clinicians etiological clues when symptoms overlap, and can be read together with inflammation markers.
Goldsite offers multi-pathogen and single-pathogen rapid antigen tests, as well as SARS-CoV-2 antigen and a SARS-CoV-2 / influenza A/B antigen combo on FIA GO. These options suit fever clinics, pediatrics, emergency rooms, and on-site screening during seasonal peaks of respiratory illness.
Goldsite’s strength is that the inflammation and infection indicators commonly used in pneumonia management are available on platforms of different throughput and for different care settings. Central laboratories can run high-volume, multi-assay workflows; clinics and emergency rooms can complete quantitative or screening tests on site; and the same set of indicators can be used from the first visit through admission and treatment follow-up.
Aristo is a fully automated nephelometry system for high-volume laboratories, rated at 200 samples per hour, with more than 45 assays. The inflammation menu includes hsCRP+CRP, CRP, UsCRP and SAA, and laboratories can set combos such as CRP+SAA. It suits central laboratories that need to run pneumonia-related inflammation testing as part of a routine specific-protein or high-throughput workflow.
GPP-100 is a compact, cartridge-based, fully automatic specific protein analyzer for quantitative testing. Its inflammation menu lists FR-CRP, CRP and SAA, with sample types of whole blood, plasma or serum depending on the assay. The small footprint and ready-to-use cartridges suit space-limited laboratories, department labs, and sites that want a flexible CRP and SAA service.
Omlipo is a fully automated nephelometry system for mid- to high-throughput laboratories, rated at 100 tests per hour, with more than 45 assays. Its menu includes bCRP, UsCRP, CRP and SAA, and also supports a CRP+SAA inflammation combo. It suits laboratories whose sample volume is growing and that want routine specific-protein and inflammation assays on one system.
FIA GO is a time-resolved fluorescence immunoassay (TRFIA) analyzer that delivers quantitative results in minutes. It is designed for timely care at the physician’s office, and can also be used to monitor infection and immunity. The inflammation menu covers hsCRP/CRP, SAA, PCT, IL-6 and a PCT/IL-6 combo on one system; the infectious menu includes SARS-CoV-2 antigen and a SARS-CoV-2 / influenza A/B antigen combo. In pneumonia-related care, the same analyzer can therefore provide inflammation and infection markers and screen for common viral antigens, which suits clinics, emergency rooms and departments that want testing close to the patient.
On the 4-in-1 and 6-in-1 combo kits, results are given in 15 minutes. Multi-pathogen combos reduce the need for separate samples and separate tests, so a set of pathogen clues can be obtained quickly when respiratory symptoms overlap, and then read together with inflammation markers such as CRP and SAA.
| Clinics, general practice and pediatrics GPP-100 or FIA GO for quantitative inflammation testing such as CRP and SAA; rapid antigen combos or the FIA GO infectious menu when pathogen clues are needed. | Emergency and STAT settings FIA GO or Kemilo for CRP, PCT and IL-6 in the department, reducing the wait for central-lab turnaround; antigen combos for rapid screening of common pathogens. |
| Central laboratories Aristo or Omlipo for high-throughput admission baselines, treatment follow-up and routine inflammation testing, with SAA combo testing where needed, to provide a stable pneumonia-related inflammation monitoring. | Inpatient follow-up The same group of indicators can be followed over time, with Aristo or Omlipo in the laboratory and FIA GO at the bedside or in the department, so the test menu stays consistent and results remain comparable. |
See Specific Protein (Aristo, GPP-100) and POCT · TRFIA (FIA GO) at MEDICA 2026, 16 to 19 November, Messe Düsseldorf, Hall 1 · Stand B56.
Focusing on In Vitro Diagnostics R&D and Manufacturing Since 1999.
Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. For over 27 years, we have been developing and producing high-quality IVD products — from China’s first Specific Protein Analyzer to today’s nephelometry, HPLC HbA1c, POCT, hematology and biochemistry lines.
Since establishment, Goldsite has been committed to the research and development (R&D), manufacturing and marketing of IVD products. Our market presence currently spreads from across China to more than 100 countries.
Learn more at en.goldsite.com.cn.
Home Products About Goldsite Support Solutions Download News Contact Us Privacy Policy